###begin article-title 0
Association study of genetic variants of pro-inflammatory chemokine and cytokine genes in systemic lupus erythematosus
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 256 268 256 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RANTES, IL-8</italic>
###xml 270 279 270 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-1&#945;</italic>
###xml 285 291 281 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MCP-1 </italic>
Several lines of evidence suggest that chemokines and cytokines play an important role in the inflammatory development and progression of systemic lupus erythematosus. The aim of this study was to evaluate the relevance of functional genetic variations of RANTES, IL-8, IL-1alpha, and MCP-1 for systemic lupus erythematosus.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 124 136 124 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RANTES, IL-8</italic>
###xml 138 147 138 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-1&#945;</italic>
###xml 153 159 149 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MCP-1 </italic>
###xml 35 43 <span type="species:ncbi:9606">patients</span>
The study was conducted on 500 SLE patients and 481 ethnically matched healthy controls. Genotyping of polymorphisms in the RANTES, IL-8, IL-1alpha, and MCP-1 genes were performed using a real-time polymerase chain reaction (PCR) system with pre-developed TaqMan allelic discrimination assay.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 147 153 147 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RANTES</italic>
###xml 155 159 155 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-8</italic>
###xml 161 170 161 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-1&#945;</italic>
###xml 176 182 172 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MCP-1 </italic>
###xml 39 47 <span type="species:ncbi:9606">patients</span>
No significant differences between SLE patients and healthy controls were observed when comparing genotype, allele or haplotype frequencies of the RANTES, IL-8, IL-1alpha, and MCP-1 polymorphisms. In addition, no evidence for association with clinical sub-features of SLE was found.
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
###xml 62 68 62 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RANTES</italic>
###xml 70 85 70 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-8, IL-1&#945;</italic>
###xml 91 97 87 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MCP-1 </italic>
These results suggest that the tested functional variation of RANTES, IL-8, IL-1alpha, and MCP-1 genes do not confer a relevant role in the susceptibility or severity of SLE in the Spanish population.
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 530 531 530 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 722 723 722 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 724 725 724 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 988 989 988 989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 990 991 990 991 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 1179 1180 1179 1180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 1181 1182 1181 1182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 1282 1283 1282 1283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1284 1285 1284 1285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1224 1232 <span type="species:ncbi:9606">patients</span>
Systemic lupus erythematosus (SLE) is a chronic and systemic autoimmune disease with a complex pathogenesis involving multiple genetic and environmental factors. The disease is characterized by autoantibody production, abnormalities of immune-inflammatory system function and inflammatory manifestation in several organs. Although the pathogenesis of SLE is unknown, the increased concordance of SLE in monozygotic versus dizygotic twins and familial clustering provide evidences for the role of genetic factors in this disorder [1]. However, the genetic background of SLE is thought to be complex and involves multiple genes encoding different molecules with significant functions in the regulation of the immune system [1-4]. Among the genetic factors believed to influence susceptibility to SLE, the major histocompatibility complex (MHC) alleles show the most significant association. Importantly, several recent studies show that non-HLA genes play a role in the development of SLE [1-4]. In this respect, there are several lines of evidence that chemokines and cytokines play an important role in the inflammatory development and progression of autoimmune diseases as SLE [5-7]. Furthermore, it has been show that SLE patients show an up-regulation of inflammatory molecules [8,9].
###end p 11
###begin p 12
###xml 65 71 65 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RANTES</italic>
###xml 89 93 89 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-8</italic>
###xml 135 140 135 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MCP-1</italic>
###xml 323 325 323 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 326 328 326 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 365 370 365 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-8 </italic>
###xml 374 379 374 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MCP-1</italic>
###xml 486 488 486 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 489 491 489 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 541 547 541 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RANTES</italic>
###xml 549 553 549 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL8 </italic>
###xml 557 562 557 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MCP-1</italic>
###xml 731 732 731 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 891 893 891 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1062 1069 1062 1069 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RANTES </italic>
###xml 1127 1132 1127 1132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-8 </italic>
###xml 1183 1189 1183 1189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MCP-1 </italic>
###xml 1267 1269 1267 1269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1270 1272 1270 1272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 596 604 <span type="species:ncbi:9606">patients</span>
###xml 853 861 <span type="species:ncbi:9606">patients</span>
###xml 1050 1055 <span type="species:ncbi:9606">human</span>
Regulated upon activation, normal T cell expressed and secreted (RANTES), interleukin 8 (IL-8) and monocyte chemoattractant protein-1 (MCP-1) are involved in the physiology and pathophysiology of acute and chronic inflammatory processes, by recruitment of monocytes, T lymphocytes and eosinophils to sites of inflammation [10,11]. Substantial evidence suggest that IL-8 and MCP-1, contribute to kidney injury in the glomerulonephritis of SLE, through glomerular leukocyte infiltration [12,13]. Serum levels of these inflammatory chemokines (RANTES, IL8 and MCP-1) are significantly higher in SLE patients than in control subjects, and correlated significant with SLEDAI score, suggesting a role in the pathogenesis of the disease [9]. As a consequence of renal disease, increased urine MCP-1 and urine IL-8 (uMCP-1, uIL-8) levels can be detected in SLE patients during active renal disease [14]. Interestingly some genetic variants within regulatory regions of these genes can affect the transcriptional activity and subsequent protein expression in human. For, RANTES the SNPs -403 G/A (rs2107538) and R3 (rs2306630) T/C, for IL-8 -353 T/A (rs4073) and for +781 C/T (rs2227306) and MCP-1 -2518 G/A (rs1024611) have been correlated to mRNA and or protein expression [15-17].
###end p 12
###begin p 13
###xml 34 44 34 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-1&#945; </italic>
###xml 275 285 271 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-1&#945; </italic>
###xml 436 446 428 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-1&#945; </italic>
###xml 471 481 459 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-1&#945; </italic>
###xml 522 524 506 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
In addition to these three genes, IL-1alpha also constitutes a strong candidate gene for SLE, since it is a proinflammatory cytokine that plays and important role in initiating and modulating the immune responses. There is a functional polymorphism in the promoter region of IL-1alpha gene at position -889 C/T (rs1800587), and the -889 C homozygous genotype has been associated with significantly lower transcriptional activity of the IL-1alpha gene and lower levels of IL-1alpha in plasma compared with the TT genotype [18].
###end p 13
###begin p 14
###xml 24 30 24 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RANTES</italic>
###xml 32 36 32 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-8</italic>
###xml 38 43 38 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MCP-1</italic>
###xml 56 66 56 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-1&#945; </italic>
Overall, the chemokines RANTES, IL-8, MCP-1and cytokine IL-1alpha are strong candidate genes for which genetic association studies can shed light on the underlying mechanisms causing the immune dysregulation, such as inappropriate T cell activation or trafficking in SLE.
###end p 14
###begin p 15
###xml 104 110 104 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RANTES</italic>
###xml 112 116 112 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-8</italic>
###xml 118 124 118 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MCP-1 </italic>
###xml 128 138 128 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-1&#945; </italic>
Therefore, the aim of this work was to test for association of the reported functional polymorphisms in RANTES, IL-8, MCP-1 and IL-1alpha with SLE susceptibility.
###end p 15
###begin title 16
Methods
###end title 16
###begin title 17
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients
###end title 17
###begin p 18
###xml 161 163 161 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 83 91 <span type="species:ncbi:9606">patients</span>
###xml 172 180 <span type="species:ncbi:9606">patients</span>
###xml 539 546 <span type="species:ncbi:9606">patient</span>
###xml 665 673 <span type="species:ncbi:9606">patients</span>
###xml 679 684 <span type="species:ncbi:9606">women</span>
###xml 706 714 <span type="species:ncbi:9606">patients</span>
Peripheral blood samples were obtained after written informed consent from 500 SLE patients meeting the American College of Rheumatology (ACR) criteria for SLE [19]. These patients were recruited from five Spanish hospitals: Hospital Virgen de las Nieves and Hospital Clinico (Granada), Hospital Virgen del Rocio (Seville) and Hospital Carlos-Haya and Hospital Virgen de la Victoria (Malaga). Similarly, blood was taken from 481 blood bank and bone marrow donors of the corresponding cities that were included as healthy individuals. Both patient and control groups were of Spanish Caucasian origin and were matched for age and sex. Eighty seven percent of the SLE patients were women, the mean age of SLE patients at diagnosis was 43 +/- 13.3 years and the mean age at disease onset of SLE symptoms was 32 +/- 15 years. The SLE clinical manifestations studied were articular involvement (76%), renal affectation (37%), cutaneous lesions (62%), hematopoietic alterations (73%), photosensivity (51%), neurological disease (17%) and serositis (28%). The study was approved by all local ethical committees from the corresponding hospitals.
###end p 18
###begin title 19
Genotyping
###end title 19
###begin p 20
###xml 117 118 117 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 341 342 339 340 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
For all the considered SNPs, samples were genotyped using a pre-developed TaqMan allelic discrimination assay. Table 1 shows the part number and reference of each SNP (Applied Biosystems, Foster City, CA, USA). PCR was carried out with mixes consisting of 8 ng of genomic DNA, 2.5 mul of Taqman master mix, 0.125 mul of 20x assay mix and ddH2O up to 5 mul of final volume. The following amplification protocol was used: denaturation at 95degreesC for 10 min, followed by 40 cycles of denaturation at 92degreesC for 15 sec and annealing and extension at 60degreesC for 1 min. After PCR, the genotype of each sample was attributed automatically by measuring the allelic specific fluorescence on the ABI PRISM 7900 Sequence Detection Systems using the SDS 2.2.2 software for allelic discrimination (Applied Biosystems, Foster City, CA, USA).
###end p 20
###begin p 21
Taqman probes part number used for genotyping.
###end p 21
###begin title 22
Statistic analysis
###end title 22
###begin p 23
###xml 627 629 627 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 632 634 632 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
Allele and genotype frequencies were obtained by direct counting. Hardy-Weinberg equilibrium and statistical analysis to compare allelic and genotypic distributions were performed using the chi-square test. Odds ratio (OR) with 95% confidence intervals (95%CI) were calculated according to Woolf's method. The software used was StatCalc program (Epi Info 2002; Centers of Disease Control and Prevention, Atlanta, GA, USA). For the haplotype analysis, pair-wise linkage disequilibrium measures were investigated and haplotypes were constructed using the expectation-maximization (EM) algorithm implemented in UNPHASED software [20]. P values below 0.05 were considered statistically significant. The power of the study to detect an effect of a polymorphism in disease susceptibility was estimated using the Quanto v 0.5 software (Department of Preventive Medicine University of Southern California, CA, USA).
###end p 23
###begin title 24
Results
###end title 24
###begin p 25
###xml 6 7 6 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 58 64 58 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RANTES</italic>
###xml 65 69 65 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-8</italic>
###xml 71 80 71 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-1&#945;</italic>
###xml 86 92 82 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MCP-1 </italic>
Table 2 shows the allele and genotype distribution of the RANTES,IL-8, IL-1alpha, and MCP-1 polymorphisms. For all polymorphisms, the distribution of genotypes did not deviate from that expected from populations in Hardy-Weinberg equilibrium.
###end p 25
###begin p 26
###xml 35 41 35 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RANTES</italic>
###xml 43 47 43 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-8</italic>
###xml 49 55 49 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MCP-1 </italic>
###xml 59 69 59 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-1&#945; </italic>
###xml 90 98 <span type="species:ncbi:9606">patients</span>
Allele and genotype frequencies of RANTES, IL-8, MCP-1 and IL-1alpha polymorphisms in SLE patients and healthy controls.
###end p 26
###begin title 27
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RANTES </italic>
RANTES typing
###end title 27
###begin p 28
###xml 14 21 14 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RANTES </italic>
###xml 137 138 137 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 361 362 361 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 74 82 <span type="species:ncbi:9606">patients</span>
###xml 263 271 <span type="species:ncbi:9606">patients</span>
Genotyping of RANTES -403 G/A and R3 T/C was performed in 500 and 442 SLE patients and 481 and 438 healthy controls, respectively (table 2). No statistically significant differences were observed when the allele and genotype distribution was compared between SLE patients and healthy controls. Also, we found no association for the two marker haplotypes (table 3).
###end p 28
###begin p 29
###xml 26 33 26 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RANTES </italic>
###xml 37 42 37 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-8 </italic>
###xml 63 71 <span type="species:ncbi:9606">patients</span>
Haplotype frequencies for RANTES and IL-8 polymorphisms in SLE patients and controls.
###end p 29
###begin title 30
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-8 </italic>
IL-8 typing
###end title 30
###begin p 31
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-8 </italic>
###xml 327 332 327 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-8 </italic>
###xml 542 544 542 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 589 590 589 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 61 69 <span type="species:ncbi:9606">patients</span>
###xml 223 231 <span type="species:ncbi:9606">patients</span>
###xml 518 526 <span type="species:ncbi:9606">patients</span>
IL-8 -353 T/A and +781 C/T was genotyping in 439 and 467 SLE patients and 412 and 429 healthy controls, respectively for each polymorphism. We found a similar distribution in the allele and genotype frequencies between SLE patients and controls for both genetic variants. The haplotype estimation for the -353 T/A and +781 C/T IL-8 polymorphisms revealed a strong degree of linkage disequilibrium between the two variants (D' = 0.9) and showed a slight but non-significant increase of the -353T-+781C haplotype in SLE patients (8.5% vs 6.2%, P = 0.08, OR = 1.41, 95%CI = 0.94-2.10) (Table 3).
###end p 31
###begin title 32
###xml 0 10 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-1&#945; </italic>
IL-1alpha typing
###end title 32
###begin p 33
###xml 0 10 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-1&#945; </italic>
###xml 37 45 <span type="species:ncbi:9606">patients</span>
###xml 178 186 <span type="species:ncbi:9606">patients</span>
IL-1alpha -889 was typing in 417 SLE patients and 420 healthy controls. We did not find any significant difference when allele and genotype frequencies were compared between SLE patients and healthy controls.
###end p 33
###begin title 34
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MCP-1 </italic>
MCP-1 typing
###end title 34
###begin p 35
###xml 6 7 6 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 57 63 57 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MCP-1 </italic>
###xml 197 203 197 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MCP-1 </italic>
###xml 97 105 <span type="species:ncbi:9606">patients</span>
###xml 249 257 <span type="species:ncbi:9606">patients</span>
Table 2 show the allele and genotype distribution of the MCP-1 -2518 A/G polymorphism in 450 SLE patients and 427 controls. No significant differences in the allele and genotype frequencies of the MCP-1 -2518 A/G polymorphism were found between SLE patients and controls.
###end p 35
###begin p 36
###xml 323 330 323 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RANTES </italic>
###xml 336 343 336 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RANTES </italic>
###xml 347 357 347 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-1&#945; </italic>
###xml 366 372 362 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MCP-1 </italic>
###xml 453 454 449 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 467 472 463 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-8 </italic>
###xml 800 801 796 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 44 52 <span type="species:ncbi:9606">patients</span>
###xml 188 196 <span type="species:ncbi:9606">patients</span>
###xml 404 412 <span type="species:ncbi:9606">patients</span>
###xml 570 578 <span type="species:ncbi:9606">patients</span>
###xml 611 619 <span type="species:ncbi:9606">patients</span>
In addition, available clinical features of patients with SLE were analysed for possible association with the different alleles or genotypes of these polymorphisms. When we stratified SLE patients according to the presence of renal involvement, no statistically significant differences were observed in the distribution of RANTES -403, RANTES R3, IL-1alpha -889 and MCP-1 -2518 polymorphisms between SLE patients with and without lupus nephritis (table 4). Regarding IL-8 polymorphisms, the AT -353 genotype and the -353T/+781C haplotype showed an increased among lupus patients without nephritis compared with patients with nephritis (39.2% vs 49.4%, P = 0.03, OR = 0.66, 95%CI = 0.44-0.99 for AT -353 genotype) (5.7% vs 10%, P = 0.05, OR = 0.55, 95%CI = 0.28-1.05 for -353T/+781C haplotype) (table 4).
###end p 36
###begin p 37
###xml 21 27 21 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RANTES</italic>
###xml 29 33 29 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-8</italic>
###xml 35 41 35 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MCP-1 </italic>
###xml 45 55 45 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-1&#945; </italic>
###xml 114 122 <span type="species:ncbi:9606">patients</span>
Relationship between RANTES, IL-8, MCP-1 and IL-1alpha polymorphisms and the presence of nephritis in SLE Spanish patients.
###end p 37
###begin p 38
Similarly, no significant differences were observed between all these genetic variants and the following variables: sex, age at onset, articular involvement, cutaneous lesions, photosensitivity, hematological alterations, neurological disorders and serositis (data not shown).
###end p 38
###begin title 39
Discussion
###end title 39
###begin p 40
###xml 159 166 159 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RANTES </italic>
###xml 185 190 185 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-8 </italic>
###xml 212 222 212 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-1&#945; </italic>
###xml 237 243 233 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MCP-1 </italic>
###xml 326 331 322 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-8 </italic>
In this work, we have tested six functional polymorphisms of four strong candidate genes for association with SLE. No evidence of association was detected for RANTES (-403 G/A, R3 T/C),IL-8 (-353 A/T, +781 C/T), IL-1alpha (-889C/T), and MCP-1 (-2518 G/A) polymorphisms. However, a significant association was observed for the IL-8 haplotype with SLE nephritis, which cannot be considered as significant after correction for multiple comparisons.
###end p 40
###begin p 41
###xml 131 133 131 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 134 136 134 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 137 139 137 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 205 212 205 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RANTES </italic>
###xml 330 337 330 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RANTES </italic>
###xml 366 368 366 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 369 371 369 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 462 464 462 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
All these genes have been previously associated with susceptibility and development to several autoimmune disorders, included SLE [16,21-27]. For example, recent studies in Asian populations found another RANTES polymorphism (-28C/G) to be associated with increased risk of developing SLE, but failed to detect any association of RANTES -403 polymorphisms with SLE [22,23]. We did not test the -28C/G variant as -28G allele is relatively uncommon in Caucasians [28].
###end p 41
###begin p 42
###xml 20 25 20 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-8 </italic>
###xml 123 125 123 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 200 202 200 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 203 205 203 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 320 325 320 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-8 </italic>
###xml 476 484 <span type="species:ncbi:9606">patients</span>
The genetic variant IL-8 -845C showed a high association to severe lupus nephritis (LN) in an African American population [16], but also this allele has a very low frequency in Caucasian populations [16,29]. The trend of association that we have found between the haplotypes and LN and the reported association of other IL-8 variants this African American population, shows that variants in this chemokine may have a minor influence on the risk of developing nephritis in SLE patients.
###end p 42
###begin p 43
###xml 70 80 70 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-1&#945; </italic>
###xml 197 199 193 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 221 227 217 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MCP-1 </italic>
###xml 442 443 438 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 372 380 <span type="species:ncbi:9606">patients</span>
Similar observation could be made for the reported association of the IL-1alpha -889C/T variant to SLE in a White and African American populations from United States, which we failed to replicate [30]. With regard to the MCP-1 -2518 polymorphism, an American study showed that an A/G or G/G genotype may predispose to the development of SLE and further indicated that SLE patients with these genotypes may be at higher risk of developing LN [3].
###end p 43
###begin p 44
###xml 517 519 517 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 520 522 520 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 523 525 523 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 526 528 526 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 732 734 732 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
The fact that we do not observe an association and fail to confirm some previous studies may be caused by a Type II error (false-negative). This is however unlikely because our sample has more than 80% power to detect the relative risk similar to the other studies at the 5% significance level. Furthermore, the genotype frequencies did not differ from Hardy-Weinberg expectations, and allele and genotype frequencies in our Spanish population are similar to those reported previously in other Caucasian populations [16,26,31,32]. The failure to replicate reported associations is a common event in the search for genetic determinants of complex diseases, due either to genuine population heterogeneity or a different sort of bias [33]. The lack of replication in our population may alternatively be explained by a different racial composition of that study from ours, or that presence of environmental factors to which the Asian, American, and African populations, but not the Spanish population, are exposed. In addition, genetic differences are known to exist between the different ethnic groups, such as, African American and Caucasians.
###end p 44
###begin title 45
Conclusion
###end title 45
###begin p 46
###xml 73 79 73 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RANTES</italic>
###xml 81 85 81 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-8</italic>
###xml 87 96 87 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-1&#945;</italic>
###xml 102 108 98 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MCP-1 </italic>
In conclusion, our results suggest that functional genetics variation in RANTES, IL-8, IL-1alpha, and MCP-1 do not play a major role in SLE susceptibility in the Spanish population.
###end p 46
###begin title 47
Competing interests
###end title 47
###begin p 48
The author(s) declare that they have no competing interests.
###end p 48
###begin title 49
Authors' contributions
###end title 49
###begin p 50
ES carried out the genotyping and statistical analysis and drafted the manuscript, JMS collected the samples, JLC collected the samples, EDR collected the samples, RGP collected the samples, FJGH collected the samples, JJA collected the samples, MFGE collected the samples, JM participated in the manuscript design and coordination and helped to draft the manuscript, BK participated in the manuscript design, reviewed the statistical analysis and helped to draft the manuscript.
###end p 50
###begin title 51
Pre-publication history
###end title 51
###begin p 52
The pre-publication history for this paper can be accessed here:
###end p 52
###begin p 53

###end p 53
###begin title 54
Acknowledgements
###end title 54
###begin p 55
This work was supported by grant SAF03-3460 from Plan Nacional de I+D+I, and in part by the Junta de Andalucia, grupo CTS-180. We thank Sasha Zhernakova for her excellent technical assistance. Finally, we thank Cisca Wijmenga for support.
###end p 55
###begin article-title 56
Delineating the genetic basis of systemic lupus erythematosus
###end article-title 56
###begin article-title 57
Systemic lupus erythematosus genome scan: support for linkage at 1q23, 2q33, 16q12-13, and 17q21-23 and novel evidence at 3p24, 10q23-24, 13q32, and 18q22-23
###end article-title 57
###begin article-title 58
Strong association of a functional polymorphism in the monocyte chemoattractant protein 1 promoter gene with lupus nephritis
###end article-title 58
###begin article-title 59
The genetic basis of systemic lupus erythematosus--knowledge of today and thoughts for tomorrow
###end article-title 59
###begin article-title 60
The polymorphism of monocyte chemoattractant protein-1 is associated with the renal disease of SLE
###end article-title 60
###begin article-title 61
Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus
###end article-title 61
###begin article-title 62
Synergistic effect between IL-10 and bcl-2 genotypes in determining susceptibility to systemic lupus erythematosus
###end article-title 62
###begin article-title 63
###xml 85 93 <span type="species:ncbi:9606">patients</span>
Production of IL-1beta, IL-1 receptor antagonist and IL-10 by mononuclear cells from patients with SLE
###end article-title 63
###begin article-title 64
###xml 81 89 <span type="species:ncbi:9606">patients</span>
Raised plasma concentration and ex vivo production of inflammatory chemokines in patients with systemic lupus erythematosus
###end article-title 64
###begin article-title 65
Mast cells in basal cell carcinoma express VEGF, IL-8 and RANTES
###end article-title 65
###begin article-title 66
Monocyte chemoattractant protein-1 promotes macrophage-mediated tubular injury, but not glomerular injury, in nephrotoxic serum nephritis
###end article-title 66
###begin article-title 67
Chemotactic factors and renal inflammation
###end article-title 67
###begin article-title 68
Chemokines: therapeutic targets for autoimmune and inflammatory renal disease
###end article-title 68
###begin article-title 69
###xml 34 39 <span type="species:ncbi:9606">human</span>
Urine chemokines as biomarkers of human systemic lupus erythematosus activity
###end article-title 69
###begin article-title 70
###xml 50 55 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression
###end article-title 70
###begin article-title 71
A novel interleukin-8 polymorphism is associated with severe systemic lupus erythematosus nephritis
###end article-title 71
###begin article-title 72
A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression
###end article-title 72
###begin article-title 73
Cloning and functional analysis of the allelic polymorphism in the transcription regulatory region of interleukin-1 alpha
###end article-title 73
###begin article-title 74
Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus
###end article-title 74
###begin article-title 75
Pedigree disequilibrium tests for multilocus haplotypes
###end article-title 75
###begin article-title 76
RANTES promoter polymorphism as a genetic risk factor for rheumatoid arthritis in the Chinese
###end article-title 76
###begin article-title 77
###xml 125 133 <span type="species:ncbi:9606">children</span>
Polymorphisms in the promoter region of RANTES and the regulatory region of monocyte chemoattractant protein-1 among Chinese children with systemic lupus erythematosus
###end article-title 77
###begin article-title 78
Polymorphisms in the promoter region of RANTES in Han Chinese and their relationship with systemic lupus erythematosus
###end article-title 78
###begin article-title 79
RANTES gene polymorphism in polymyalgia rheumatica, giant cell arteritis and rheumatoid arthritis
###end article-title 79
###begin article-title 80
Lack of association between pro-inflammatory cytokine (IL-6, IL-8 and TNF-alpha) gene polymorphisms and Graves' disease
###end article-title 80
###begin article-title 81
IL-1 genes in myasthenia gravis: IL-1A -889 polymorphism associated with sex and age of disease onset
###end article-title 81
###begin article-title 82
Polymorphisms of chemokine and chemokine receptor genes in Type 1 diabetes mellitus and its complications
###end article-title 82
###begin article-title 83
###xml 60 63 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort Study
###end article-title 83
###begin article-title 84
Distribution of novel polymorphisms of the interleukin-8 and CXC receptor 1 and 2 genes in systemic sclerosis and cryptogenic fibrosing alveolitis
###end article-title 84
###begin article-title 85
Systemic lupus erythematosus and genetic variation in the interleukin 1 gene cluster: a population based study in the southeastern United States
###end article-title 85
###begin article-title 86
Chemokines (RANTES and MCP-1) and chemokine-receptors (CCR2 and CCR5) gene polymorphisms in Alzheimer's and Parkinson's disease
###end article-title 86
###begin article-title 87
###xml 39 47 <span type="species:ncbi:9606">patients</span>
MCP-1 promoter polymorphism in Spanish patients with systemic lupus erythematosus
###end article-title 87
###begin article-title 88
Replication validity of genetic association studies
###end article-title 88

